跳至主要内容
临床试验/CTRI/2022/07/043692
CTRI/2022/07/043692已完成未知

Pharmacognostical study on Agnimantha with special reference to its role in Sthaulya (Obesity).

Deparment of dravyaguna0 个研究点目标入组 63 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient age group ranging from 18-65 years.
  • 2. Body Mass index > 30.00kg/m2 and <= 40.00kg/m2
  • 3. Waist Circumference >= 102 cm for males and >= 88cm for females.
  • 4. Waist: Hip ratio >= 0.95 for males and >= 0.80 for females.
  • 5. Abnormal lipid profile.

排除标准

  • 1. Patient having BMI >40.00
  • 2. Patient with IDDM and severe hypertension.
  • 3. Patient with severe cardiac and endocrine disease.
  • 4. Patient not giving consent.
  • 5. Obesity due to medicines e.g., Steroids, Contraceptive pills etc.

研究者

发起方
Deparment of dravyaguna

相似试验